You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: multiple doses of antenatal corticosteroids prevent preterm neonatal respiratory disease more than a single dose

https://doi.org/10.1136/ebm.13.3.81

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Dr C Crowther

    Correspondence to: Dr C Crowther, University of Adelaide, Adelaide, South Australia, Australia; caroline.crowther@adelaide.edu.au

    QUESTION

    In women at risk of preterm birth, what is the effectiveness and safety of multiple doses of antenatal corticosteroids (ACSs) compared with a single dose for preventing neonatal respiratory disease?

    REVIEW SCOPE

    Studies comparing repeat dose(s) of ACSs with placebo or no treatment for preventing neonatal morbidity in women still at risk of preterm delivery ⩾7 days after a first dose were selected. Outcomes were respiratory distress syndrome, severe lung disease, serious infant morbidity, birthweight, perinatal mortality, and maternal morbidity.

    REVIEW METHODS

    Cochrane Pregnancy and Childbirth Group’s trials register (February 2007); Cochrane Central Register of Controlled Trials, Medline, EMBASE/Excerpta Medica, and Current Contents (to November 2006); reference lists; and abstracts of major congresses were searched for randomised controlled trials (RCTs). Experts …

    View Full Text

    Footnotes

    • Source of funding: Australian Department of Health and Aging.